7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Hypercholesterolemia D006937 91 associated lipids
Bone Diseases, Metabolic D001851 9 associated lipids
Adrenal Hyperplasia, Congenital D000312 2 associated lipids
Obesity D009765 29 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Myocardial Infarction D009203 21 associated lipids
Femur Head Necrosis D005271 5 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Malocclusion D008310 3 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Periodontal Diseases D010510 15 associated lipids
Osteitis Deformans D010001 3 associated lipids
Dental Pulp Necrosis D003790 6 associated lipids
Crohn Disease D003424 12 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Fractures, Stress D015775 2 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
Thyroid Diseases D013959 8 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Myocardial Ischemia D017202 11 associated lipids
Paraneoplastic Syndromes D010257 4 associated lipids
Sepsis D018805 11 associated lipids
Periodontal Pocket D010514 9 associated lipids
Brain Infarction D020520 17 associated lipids
Hirsutism D006628 3 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Hypocalcemia D006996 12 associated lipids
Brain Ischemia D002545 89 associated lipids
Endocrine System Diseases D004700 4 associated lipids
Nerve Degeneration D009410 53 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Periodontitis D010518 22 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Polycythemia Vera D011087 13 associated lipids
Mucocutaneous Lymph Node Syndrome D009080 9 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Cardiomyopathies D009202 10 associated lipids
Disease Susceptibility D004198 12 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Zhou QL et al. Polydatin possesses notable anti‑osteoporotic activity via regulation of OPG, RANKL and β‑catenin. 2016 Mol Med Rep pmid:27357904
Lu J et al. Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. 2016 Exp. Biol. Med. (Maywood) pmid:26908571
Stuss M et al. Assessment of OPG, RANKL, bone turnover markers serum levels and BMD after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. 2016 Endokrynol Pol pmid:26884284
Gluba-Brzózka A et al. Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. 2016 Lipids Health Dis pmid:26843213
Chen H et al. [Effects of laser solid forming of porous titanium on proliferation of osteoblast and RANKL/OPG expression]. 2016 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:28070039
Shimazaki E et al. TGF-β and Physiological Root Resorption of Deciduous Teeth. 2016 Int J Mol Sci pmid:28035998
Zhang YY et al. Osteoprotegerin Promotes Cementoblastic Activity of Murine Cementoblast Cell Line in vitro. 2016 Chin J Dent Res pmid:27379348
Songia P et al. Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. 2016 J. Mol. Cell. Cardiol. pmid:27338002
Li Y et al. OPG and RANKL polymorphisms are associated with alcohol-induced osteonecrosis of the femoral head in the north area of China population in men. 2016 Medicine (Baltimore) pmid:27336899
Dolan EB et al. Thermally induced osteocyte damage initiates pro-osteoclastogenic gene expression in vivo. 2016 J R Soc Interface pmid:27335224

Table of Content